Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Glaukos (GKOS) EBT (2016 - 2025)

Glaukos (GKOS) has disclosed EBT for 12 consecutive years, with -$144.4 million as the latest value for Q4 2025.

  • Quarterly EBT fell 328.59% to -$144.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$197.6 million through Dec 2025, down 35.74% year-over-year, with the annual reading at -$197.6 million for FY2025, 35.74% down from the prior year.
  • EBT for Q4 2025 was -$144.4 million at Glaukos, down from -$16.0 million in the prior quarter.
  • The five-year high for EBT was $101.5 million in Q4 2023, with the low at -$144.4 million in Q4 2025.
  • Average EBT over 5 years is -$24.4 million, with a median of -$25.8 million recorded in 2021.
  • Peak annual rise in EBT hit 425.68% in 2023, while the deepest fall reached 700.12% in 2023.
  • Over 5 years, EBT stood at -$24.3 million in 2021, then dropped by 28.04% to -$31.2 million in 2022, then surged by 425.68% to $101.5 million in 2023, then tumbled by 133.2% to -$33.7 million in 2024, then crashed by 328.59% to -$144.4 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$144.4 million, -$16.0 million, and -$19.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.